electroCore to Participate in Upcoming Investor Conferences
electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, has announced its participation in two upcoming investor conferences. CEO Dan Goldberger will attend the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference from August 12-13, 2024. Interested parties can contact Needham to schedule one-on-one meetings.
Additionally, CFO Brian Posner will be present at the 44th Annual Canaccord Genuity Growth Conference at the InterContinental Hotel in Boston, MA. electroCore will host investor meetings on August 13, 2024. To arrange a meeting, interested parties should contact Canaccord Genuity.
These conferences provide electroCore with opportunities to engage with investors and showcase their commercial-stage bioelectronic medicine and wellness solutions.
electroCore, Inc. (Nasdaq: ECOR), una società che si occupa di medicina bioelettronica e benessere, ha annunciato la sua partecipazione a due prossime conferenze per investitori. Il CEO Dan Goldberger parteciperà alla 9° Conferenza Annuale Virtuale MedTech & Diagnostics 1x1 di Needham che si svolgerà dal 12 al 13 agosto 2024. Le parti interessate possono contattare Needham per programmare incontri individuali.
Inoltre, Il CFO Brian Posner sarà presente alla 44° Conferenza Annuale di Canaccord Genuity Growth presso l'Hotel InterContinental di Boston, MA. electroCore ospiterà incontri con gli investitori il 13 agosto 2024. Per organizzare un incontro, le parti interessate dovrebbero contattare Canaccord Genuity.
Queste conferenze offrono a electroCore l'opportunità di interagire con gli investitori e mostrare le proprie soluzioni di medicina bioelettronica e benessere in fase commerciale.
electroCore, Inc. (Nasdaq: ECOR), una empresa de medicina bioelectrónica y bienestar, ha anunciado su participación en dos próximas conferencias para inversores. El CEO Dan Goldberger asistirá a la 9ª Conferencia Anual Virtual MedTech & Diagnostics 1x1 de Needham que se llevará a cabo del 12 al 13 de agosto de 2024. Las partes interesadas pueden contactar a Needham para programar reuniones individuales.
Además, El CFO Brian Posner estará presente en la 44ª Conferencia Anual de Canaccord Genuity Growth en el Hotel InterContinental de Boston, MA. electroCore realizará reuniones con inversores el 13 de agosto de 2024. Para organizar una reunión, las partes interesadas deben contactar a Canaccord Genuity.
Estas conferencias brindan a electroCore la oportunidad de interactuar con inversores y mostrar sus soluciones de medicina bioelectrónica y bienestar en etapa comercial.
electroCore, Inc. (Nasdaq: ECOR)는 생체 전자 의학 및 웰빙 회사로, 두 개의 다가오는 투자자 회의에 참가한다고 발표했습니다. CEO Dan Goldberger는 2024년 8월 12일부터 13일까지 진행되는 제9회 연례 Needham 가상 MedTech & Diagnostics 1x1 회의에 참석할 예정입니다. 관심 있는 분들은 1:1 미팅을 예약하기 위해 Needham에 연락할 수 있습니다.
추가로, CFO Brian Posner는 보스턴 MA에 있는 인터컨티넨탈 호텔에서 열리는 제44회 연례 Canaccord Genuity Growth 회의에 참석합니다. electroCore는 2024년 8월 13일 투자자 회의를 주최합니다. 미팅을 주선하려면 관심 있는 분들이 Canaccord Genuity에 연락해야 합니다.
이 회의들은 electroCore가 투자자와 소통하고 상업 단계의 생체 전자 의학 및 웰빙 솔루션을 선보일 수 있는 기회를 제공합니다.
electroCore, Inc. (Nasdaq: ECOR), une entreprise de médecine bioélectronique et de bien-être, a annoncé sa participation à deux prochaines conférences pour investisseurs. Le CEO Dan Goldberger assistera à la 9ème Conférence Annuelle Virtuelle MedTech & Diagnostics 1x1 de Needham qui se déroulera du 12 au 13 août 2024. Les parties intéressées peuvent contacter Needham pour programmer des réunions individuelles.
De plus, Le CFO Brian Posner sera présent à la 44ème Conférence Annuelle de Canaccord Genuity Growth à l'Hôtel InterContinental de Boston, MA. electroCore organisera des réunions avec les investisseurs le 13 août 2024. Pour organiser une rencontre, les personnes intéressées doivent contacter Canaccord Genuity.
Ces conférences offrent à electroCore l'opportunité d'interagir avec des investisseurs et de présenter ses solutions de médecine bioélectronique et de bien-être au stade commercial.
electroCore, Inc. (Nasdaq: ECOR), ein Unternehmen für bioelektronische Medizin und Wellness, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. CEO Dan Goldberger wird an der 9. jährlichen Bedarf MedTech & Diagnostics 1x1 Konferenz von Needham vom 12. bis 13. August 2024 teilnehmen. Interessierte Parteien können Needham kontaktieren, um Einzelgespräche zu planen.
Zusätzlich wird CFO Brian Posner an der 44. jährlichen Canaccord Genuity Growth Konferenz im InterContinental Hotel in Boston, MA, teilnehmen. electroCore wird am 13. August 2024 Investorenmeetings abhalten. Um ein Treffen zu arrangieren, sollten interessierte Parteien Canaccord Genuity kontaktieren.
Diese Konferenzen bieten electroCore die Möglichkeit, mit Investoren in Kontakt zu treten und ihre kommerziellen bioelektronischen Medizin- und Wellnesslösungen vorzustellen.
- None.
- None.
ROCKAWAY, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s CEO, Dan Goldberger, is scheduled to participate in the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference August 12 - 13, 2024. Please contact Needham to schedule a 1x1 meeting.
In addition, Brian Posner, CFO of electroCore, Inc. is scheduled to attend the 44th Annual Canaccord Genuity Growth Conference taking place at InterContinental Hotel in Boston, MA. electroCore will host 1x1 investor meetings on August 13, 2024. Please contact Canaccord Genuity to schedule a 1x1 meeting.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
Which investor conferences will electroCore (ECOR) participate in during August 2024?
Who will represent electroCore (ECOR) at the Needham Virtual MedTech & Diagnostics Conference?
Where will the Canaccord Genuity Growth Conference that electroCore (ECOR) is attending be held?
How can investors schedule meetings with electroCore (ECOR) at these conferences?
